Bacterial and fungal endophthalmitis

Clinical Microbiology Reviews

Volumn 30, Issue 3, 2017, Pages 597-613

  Durand, Marlene L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bacterial endophthalmitis; Bleb related endophthalmitis; Candida endophthalmitis; Endophthalmitis; Endophthalmitis prophylaxis; Fungal endophthalmitis; Keratitis related endophthalmitis; Postoperative endophthalmitis; Posttraumatic endophthalmitis

Indexed keywords

CXCL1 CHEMOKINE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

BCATERIAL ENDOPHTHALMITIS; BLEB RELATED ENDOPHTHALMITIS; CANDIDA ENDOPHTHALMITIS; CATARACT EXTRACTION; CHRONIC POSTCATARACT ENDOPHTHALMITIS; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); ENDOGENOUS BACTERIAL ENDOPHTHALMITIS; ENDOGENOUS FUNGAL ENDOPHTHALMITIS; ENDOPHTHALMITIS; EYE EXAMINATION; EYE INJURY; EYE PAIN; FUNGAL ENDOPHTHALMITIS; HUMAN; KERATITIS RELATED ENDOPHTHALMITIS; KLEBSIELLA PNEUMONIAE; MULTICENTER STUDY (TOPIC); MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; POSTINJECTION ENDOPHTHALMITIS; POSTKERATOPLASTY ENDOPHTHALMITIS; POSTOPERATIVE ENDOPHTHALMITIS; POSTTRAUMATIC ENDOPHTHALMITIS; POSTVITRECTOMY ENDOPHTHALMITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAL TIME POLYMERASE CHAIN REACTION; REVIEW; STAPHYLOCOCCUS; VITRECTOMY; BACTERIAL INFECTIONS; BACTERIUM; FUNGUS; MYCOSES; PATHOLOGY;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; ENDOPHTHALMITIS; FUNGI; HUMANS; MYCOSES; VITRECTOMY;

EID: 85016605532     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00113-16     Document Type: Review

References (86)

1. Melo GB, Bispo PJM, Yu MCZ, Pignatari AC, Höfling-Lima AL. 2011. Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis. Eye 25:382–388. https://doi.org/10.1038/eye.2010.236.
2. Gupta A, Orlans HO, Hornby SJ, Bowler ICJ. 2014. Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK. Graefes Arch Clin Exp Ophthalmol 252:1825–1830. https://doi.org/10.1007/s00417-014-2658-7.
3. Kessner R, Golan S, Barak A. 2014. Changes in the etiology of endoph thalmitis from 2003 to 2010 in a large tertiary medical center. Eur J Ophthalmol 24:918–924. https://doi.org/10.5301/ejo.5000473.
4. Falavarjani KG, Nekoozadeh S, Modarres M, Parvaresh MM, Hashemi M, Soodi R, Alemzadeh SA. 2012. Isolates and antibiotic resistance of culture-proven endophthalmitis cases presented to a referral center in Tehran. Middle East Afr J Ophthalmol 19:361–363. https://doi.org/10.4103/0974-9233.102740.
5. Moloney TP, Park J. 2014. Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review. Br J Oph thalmol 98:1492–1497. https://doi.org/10.1136/bjophthalmol-2014 -305030.
6. Nam KY, Lee JE, Lee JE, Jeung WJ, Park JM, Park JM, Chung IY, Han YS, Yun IH, Kim HW, Byon IS. 2015. Clinical features of infectious endophthalmitis in South Korea: a five-year multicenter study. BMC Infect Dis 15:177–183. https://doi.org/10.1186/s12879-015-0900-5.
7. Sharma S, Padhi TR, Basu S, Kar S, Roy A, Das T. 2014. Endophthalmitis patients seen in a tertiary eye care centre in Odisha: a clinicomicrobiological analysis. Indian J Med Res 139:91–98.
8. Gharamah AA, Moharram AM, Ismail MA, Al-Hussaini AK. 2012. Bacterial and fungal endophthalmitis in Upper Egypt: related species and risk factors. Asian Pac J Trop Biomed 2:655–659. https://doi.org/10.1016/S2221-1691(12)60115-4.
9. Duan F, Wu K, Liao J, Zheng Y, Yuan Z, Tan J, Lin X. 2016. Causative microorganisms of infectious endophthalmitis: a 5-year retrospective study. J Ophthalmol https://doi.org/10.1155/2016/6764192.
10. Simunovic MP, Rush RB, Hunyor AP, Chang AA. 2012. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 96:862–866. https://doi.org/10.1136/bjophthalmol-2011-301439.
11. Valdez-Garcia JE, Climent A, Chavez-Mondragon E, Lozano-Ramirez JF. 2014. Anterior chamber bacterial contamination in cataract surgery. BMC Ophthalmol 14:57. https://doi.org/10.1186/1471-2415-14-57.
12. Srinivasan R, Tiroumal S, Kanungo R, Natarajan MK. 2002. Microbial contamination of the anterior chamber during phacoemulsification. J Cataract Refract Surg 28:2173–2176. https://doi.org/10.1016/S0886 -3350(02)01493-1.
13. Lundstrom M, Wejde G, Stenevi U, Thorbum W, Montan P. 2007. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 114:866–870. https://doi.org/10.1016/j.ophtha.2006.11.025.
14. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC. 2007. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dise 45:284–293. https://doi.org/10.1086/519262.
15. Wiskur BJ, Hunt JJ, Callegan MC. 2008. Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci 49:4931–4938. https://doi.org/10.1167/iovs.08 -2276.
16. Lin TL, Hsieh PF, Huang YT, Lee WC, Tsai YT, Su PA, Pan YJ, Hsu CR, Wu MC, Wang JT. 2014. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment. J Infect Dis 210:1734–1744. https://doi.org/10.1093/infdis/jiu332.
17. Parkunan SM, Callegan MC. 2016. The pathogenesis of bacterial endophthalmitis, p 17–47. In Durand ML, Miller JW, Young LH (ed), Endophthalmitis. Springer International Publishing, Basel, Switzerland.
18. Callegan MC, Kane ST, Cochran DC, Ramadan RT, Chodosh J, McLean C, Stroman DW. 2006. Virulence factor profiles and antimicrobial susceptibilities of ocular Bacillus isolates. Cur Eye Res 31:693–702. https://doi.org/10.1080/02713680600850963.
19. Callegan MC, Kane ST, Cochran DC, Gilmore MS, Gominet M, Lereclus D. 2003. Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence. Infect Immun 71:3116–3124. https://doi.org/10.1128/IAI.71.6.3116-3124.2003.
20. Callegan MC, Kane ST, Cochran DC, Novosad B, Gilmore MS, Gominet M, Lereclus D. 2005. Bacillus endophthalmitis: roles of bacterial toxins and motility during infection. Invest Ophthalmol Vis Sci 46:3233–3238. https://doi.org/10.1167/iovs.05-0410.
21. Parkunan SM, Randall CB, Astley RA, Furtado GC, Lira SA, Callegan MC. 10 June 2016. CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection. J Leukoc Biol.
22. Ng EW, Costa JR, Samiy N, Ruoff KL, Connolly E, Cousins FV, D’Amico DJ. 2002. Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis. Retina 22:622–632. https://doi.org/10.1097/00006982-200210000-00014.
23. Sanders ME, Norcross EW, Robertson ZM, Moore QC 3rd, Fratkin J, Marquart ME. 2011. The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis. Invest Ophthalmol Vis Sci 52:865–872. https://doi.org/10.1167/iovs.10-5513.
24. Baillif S, Ecochard R, Casoli E, Freney J, Burillon C, Kodjikian L. 2008. Adherence and kinetics of biofilm formation of Staphylococcus epidermidis to different types of intraocular lenses under dynamic flow con ditions. J Cataract Refract Surg 34:153–158. https://doi.org/10.1016/j.jcrs.2007.07.058.
25. Mazoteras P, Quiles MG, Martins Bispo PJ, Höfling-Lima AL, Pignatari AC, Casaroli-Marano RP. 2016. Analysis of intraocular lens biofilms and fluids after long-term uncomplicated cataract surgery. Am J Ophthalmol 169: 46–57. https://doi.org/10.1016/j.ajo.2016.06.012.
26. Jackson TL, Eykyn SJ, Graham EM, Stanford MR. 2003. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Survey Ophthalmol 48:403–423. https://doi.org/10.1016/S0039-6257(03)00054-7.
27. Lalwani GA, Flynn HW, Jr, Scott IU, Quinn CM, Berrocal AM, Davis JL, Murray TG, Smiddy WE, Miller D. 2008. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology 115: 473–476.
28. Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, McDonnell PJ. 2005. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 123:613–620. https://doi.org/10.1001/archopht.123.5.613.
29. Chiquet C, Boisset S, Cornut P-L, Maurin M. 2016 The molecular diagnosis of endophthalmitis, p 77–97. In Durand ML, Miller JW, Young LH (ed), Endophthalmitis. Springer International Publishing, Basel, Switzerland.
30. Hykin PG, Tobal K, McIntye G, Matheson MM, Towler HM, Lightman SL. 1994. The diagnosis of delayed post-operative endophthalmitis by polymerase chain reaction of bacterial DNA in vitreous samples. J Med Microbiol 40:408–415. https://doi.org/10.1099/00222615-40-6-408.
31. Chiquet C, Cornut P-L, Benito Y, Thuret G, Maurin M, Lafontaine PO, Pechinot A, Palombi K, Lina G, Bron A, Denis P, Carricajo A, Creuzot C, Romanet JP, Vandenesch F, French Institutional Endophthalmitis Study Group. 2008. Eubacterial PCR for bacterial detection and identification in 100 acute postcataract surgery endophthalmitis. Invest Ophthalmol Vis Sci 49:1971–1978. https://doi.org/10.1167/iovs.07-1377.
32. Hong BK, Lee CS, Van Gelder RN, Garg SJ. 2015. Emerging techniques for pathogen discovery in endophthalmitis. Curr Opin Ophthalmol 26: 221–225. https://doi.org/10.1097/ICU.0000000000000145.
33. Lee AY, Akileswaran L, Tibbetts MD, Garg SJ, Van Gelder RN. 2015. Identification of torque teno virus in culture-negative endophthalmitis by representational deep DNA sequencing. Ophthalmology 122: 524–530. https://doi.org/10.1016/j.ophtha.2014.09.001.
34. Vasilyev EV, Trofimov DY, Tonevitsky AG, Ilinsky VV, Korostin DO, Rebrikov DV. 2009. Torque teno virus (TTV) distribution in healthy Russian population. Virology J 6:134. https://doi.org/10.1186/1743-422X-6-134.
35. Endophthalmitis Vitrectomy Study Group. 1995. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113:1479–1496. https://doi.org/10.1001/archopht.1995.01100120009001.
36. Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA. 1997. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electropheresis. Arch Ophthalmol 115:357–361.
37. Leong JK, Shah R, McCluskey PJ, Benn RA, Taylor RF. 2002. Bacterial contamination of the anterior chamber during phacoemulsification cataract surgery. J Cataract Refract Surg 28:826–833. https://doi.org/10.1016/S0886-3350(01)01160-9.
38. Buchta V, Feuermannova A, Vasa M, Bašková L, Kutová R, Kubátová A, Vejsová M. 2014. Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery. Mycopathologia 177:115–121. https://doi.org/10.1007/s11046-013-9721-5.
39. Anand AR, Therese KL, Madhavan HN. 2000 Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol 48:123–128.
40. Sharma S, Sahu SK, Dhillon V, Das S, Rath S. 2015. Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India. J Cataract Refract Surg 41:393–399. https://doi.org/10.1016/j.jcrs.2014.05.038.
41. Doft BH, Kelsey SF, Wisniewski SR. 1998. Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study. Ophthalmology 105:707. https://doi.org/10.1016/S0161 -6420(98)94028-3.
42. Shirodkar AR, Pathengay A, Flynn HW, Albini TA, Berrocal AM, Davis JL, Lalwani GA, Murray TG, Smiddy WE, Miller D. 2012. Delayed versus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol 153:391–398. https://doi.org/10.1016/j.ajo.2011.08.029.
43. Dave VP, Schwartz SG, Flynn HW, Jr. 2014. Endophthalmitis following pars plana vitrectomy: a literature review of incidence, causative organisms, and treatment outcomes. Clin Ophthalmol 8:2183–2188. https://doi.org/10.2147/OPTH.S71293.
44. Taban M, Behrens A, Newcomb RL, Nobe MY, McDonnell PJ. 2005. Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. Arch Ophthalmol 123:605–609. https://doi.org/10.1001/archopht.123.5.605.
45. Chen JY, Jones MN, Srinivasan S, Neal TJ, Armitage WJ, Kaye SB, NHSBT Ocular Tissue Advisory Group and Contributing Ophthalmologists. 2015. OTAG audit study 18. Endophthalmitis after penetrating keratoplasty. Ophthalmology 122:25–30.
46. Wilhelmus KR, Hassan SS. 2007 The prognostic role of donor corneoscleral rim cultures in corneal transplantation. Ophthalmology 114: 440–445. https://doi.org/10.1016/j.ophtha.2006.09.006.
47. Williams GA. 2014. IVT injections: health policy implications. Rev Ophthalmol 21:62–64.
48. Fileta JB, Scott IU, Flynn HW. 2014. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina 45:143–149. https://doi.org/10.3928/23258160-20140306-08.
49. VanderBeek BL, Bonaffini SG, Ma L. 2015. The association between intravitreal steroids and post-injection endophthalmitis rates. Ophthalmology 122:2311–2315. https://doi.org/10.1016/j.ophtha.2015.07.005.
50. Lyall DAM, Tey A, Foot B, Roxburgh ST, Virdi M, Robertson C, MacEwen CJ. 2012. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) 26:1517–1526. https://doi.org/10.1038/eye.2012.199.
51. McCannel CA. 2011. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Retina 31: 654–661. https://doi.org/10.1097/IAE.0b013e31820a67e4.
52. Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C, FRCR net (FRenCh Retina specialists net). 2015. Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome. Am J Ophthalmol 160:17–25. https://doi.org/10.1016/j.ajo.2015.04.013.
53. Garg SJ, Dollin M, Hsu J, Storey P, Vander JF. 2015. Effect of a strict “no-talking” policy during intravitreal injection on post-injection endophthalmitis. Ophthalmic Surg Lasers Imaging Retina 46:1028–1034. https://doi.org/10.3928/23258160-20151027-07.
54. Goldberg RA, Flynn HW, Jr, Isom RF, Miller D, Gonzalez S. 2012. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol 153:204–208. https://doi.org/10.1016/j.ajo.2011.11.035.
55. Small KW, Chan CK, Silva-Garcia R, Walsh TJ. 2014. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone. Ophthalmology 121:952–958. https://doi.org/10.1016/j.ophtha.2013.10.040.
56. Entezari M, Karimi S, Ahmadieh H, Mahmoudi AH, Parhizgar H, Yaseri M. 2016. A large outbreak of fulminant bacterial endophthalmitis after intravitreal injection of counterfeit bevacizumab. Graefes Arch Clin Exp Ophthalmol 254:1851–1856. https://doi.org/10.1007/s00417-016-3426-7.
57. Andreoli CM, Andreoli MT, Kloek CE, Ahuero AE, Vavvas D, Durand ML. 2009. Low rate of endophthalmitis in a large series of open globe injuries. Am J Ophthalmol 147:601–608. https://doi.org/10.1016/j.ajo.2008.10.023.
58. Li XL, Zarbin MA, Bhagat N. 2015. Pediatric open globe injury: a review of the literature. J Emerg Trauma Shock 8:216–223. https://doi.org/10.4103/0974-2700.166663.
59. Bhagat N, Li X, Zarbin MA. 2016. Post-traumatic endophthalmitis, p 151–170. In Durand ML, Miller JW, Young LH (ed), Endophthalmitis. Springer International, Basel, Switzerland.
60. Cornut PL, el Youssef B, Bron A, Thuret G, Gain P, Burillon C, Romanet JP, Vandenesch F, Maurin M, Creuzot-Garcher C, Chiquet C, French Institutional Endophthalmitis Study (FRIENDS) Group. 2013. A multicentre prospective study of post-traumatic endophthalmitis. Acta Ophthalmol 91:475–482. https://doi.org/10.1111/j.1755-3768.2011.02349.x.
61. Yamamoto T, Sawada A, Mayama C, Araie M, Ohkubo S, Sugiyama K, Kuwayama Y, Collaborative Bleb-Related Infection Incidence and Treatment Study Group. 2014. The 5 year incidence of bleb-related infection and its risk factors following filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology 121:1001–1006. https://doi.org/10.1016/j.ophtha.2013.11.025.
62. Henry CR, Flynn HW, Jr, Miller D, Forster RK, Alfonso EC. 2012. infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology 119: 2443–2449. https://doi.org/10.1016/j.ophtha.2012.06.030.
63. Malihi M, Li X, Patel S, Eck T, Chu DS, Zarbin MA, Bhagat N. 14 July 2016 Infectious keratitis-associated endophthalmitis: a 14-year study. Retina. Epub ahead of print.
64. Rosenberg KD, Flynn HW, Jr, Alfonso EC, Miller D. 2006 Jul-Aug. Fusarium endophthalmitis following keratitis associated with contact lenses. Ophthalmic Surg Lasers Imaging 37:310–313.
65. Shen YC, Wang CY, Tsai HY, Lee HN. 2010. Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis. Am J Ophthalmol 149:916–921. https://doi.org/10.1016/j.ajo.2010.01.024.
66. Durand ML. 2016. Endophthalmitis: an overview, p 1–16. In Durand ML, Miller JW, Young LH (ed), Endophthalmitis. Springer International Publishing, Basel, Switzerland.
67. Okada AA, Johnson RP, Liles WC, D’Amico DJ, Baker AS. 1994. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 101:832–838.
68. Cho H, Shin YU, Siegel NH, Yu HG, Sobrin L, Patel A, Durand ML, Miller JW, Husain D 2016. Endogenous endophthalmitis in the American and Korean population: an 8-year retrospective study. Ocul Immunol Inflamm. 26:1–8.
69. Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. 2015. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol 159:498–504. https://doi.org/10.1016/j.ajo.2014.11.032.
70. Jackson TL, Paraskevopoulos T, Georgalas I. 2014. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 59:627–635. https://doi.org/10.1016/j.survophthal.2014.06.002.
71. Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ. 2011. Ocular manifestations of candidemia. Clin Infect Dis 53:262. https://doi.org/10.1093/cid/cir355.
72. Pappas PG, Kauffman CA, Andes DR, et al. 2016. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62:e1–e50. https://doi.org/10.1093/cid/civ933.
73. Mochizuki K, Sawada A, Suemonri S, Kawakami H, Niwa Y, Kondo Y, Ohkusu K, Yamada N, Ogura S, Yaguchi T, Nishimura K, Kishino S. 2013. Intraocular penetration of intravenous micafungin in inflamed human eyes. Antimicrob Agents Chemother 57:4027–4030. https://doi.org/10.1128/AAC.02300-12.
74. Kuriyan AE, Weiss KD, Flynn HW Jr, Smiddy WE, Berrocal AM, Albini TA, Miller D. 2014. Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes. Am J Ophthalmol. 157:774–780. https://doi.org/10.1016/j.ajo.2013.12.026.
75. Kuriyan AE, Sridhar J, Flynn HW Jr, Smiddy WE, Albini TA, Berrocal AM, Forster RK, Belin PJ, Miller D. 2014. Endophthalmitis caused by Enterococcus faecalis: clinical features, antibiotic sensitivities, and outcomes. Am J Ophthalmol 158:1018–1023. https://doi.org/10.1016/j.ajo.2014.07.038.
76. Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Murray TG, Berrocal A, Miller D. 2016. Endophthalmitis caused by Bacillus species. Am J Ophthalmol 145:883–888.
77. Yoder DM, Scott IU, Flynn HW Jr, Miller D. 2004. Endophthalmitis caused by Haemophilus influenzae. Ophthalmology 111:2023–2026. https://doi.org/10.1016/j.ophtha.2004.05.018.
78. Sridhar J, Kuriyan AE, Flynn HW Jr, Smiddy WE, Venincasa VD, Miller D. 2015. Endophthalmitis caused by Serratia marcescens: clinical features, antibiotic susceptibilities, and treatment outcomes. Retina 35: 1095–1100. https://doi.org/10.1097/IAE.0000000000000509.
79. Sridhar J, Kuriyan AE, Flynn HW Jr, Miller D. 2015. Endophthalmitis caused by Pseudomonas aeruginosa: clinical features, antibiotic susceptibilities, and treatment outcomes. Retina 35:1101–1106. https://doi.org/10.1097/IAE.0000000000000469.
80. Durand ML. 2016. Preventing endophthalmitis, p 261–278. In Durand ML, Miller JW, Young LH (ed), Endophthalmitis. Springer International, Basel, Switzerland.
81. ECSRS Endophthalmitis Study Group. 2007. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33:978–988. https://doi.org/10.1016/j.jcrs.2007.02.032.
82. Moisseiev E, Levinger E. 2013. Anaphylactic reaction following intracameral cefuroxime injection during cataract surgery. J Cataract Refract Surg 39:1432–1434. https://doi.org/10.1016/j.jcrs.2013.06.008.
83. Nicholson LB, Kim BT, Jardón J, Townsend-Pico W, Santos C, Moshfeghi AA, Albini TA, Eliott D, Sobrin L. 2014. Severe bilateral ischemic retinal vasculitis following cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 45:338–342. https://doi.org/10.3928/23258160-201 40605-01.
84. Witkin AJ, Shah AR, Engstrom RE, Kron-Gray MM, Baumal CR, Johnson MW, Witkin DI, Leung J, Albini TA, Moshfeghi AA, Batlle IR, Sobrin L, Eliott D. 2015. Postoperative hemorrhagic occlusive retinal vasculitis: expanding the clinical spectrum and possible association with vancomycin. Ophthalmology 122:1438–1451. https://doi.org/10.1016/j.ophtha.2015.03.016.
85. Durand ML. 2003. Eye infections, p 222–250. In Betts RF, Chapman SW, Penn RL (ed), Reese and Betts’ a practical approach to infectious diseases. Lippincott, Williams and Wilkins, Philadelphia, PA.
86. Endophthalmitis Vitrectomy Study Group. 1996. Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 122:830–846.